ATYR
aTyr Pharma, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$48.05M
P/E Ratio
—
EPS
$-0.74
Beta
0.66
52W High
$7.29
52W Low
$0.40
50-Day MA
$0.77
200-Day MA
$1.40
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About aTyr Pharma, Inc.
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 190,000 |
| Gross Profit (TTM) | $-55.53M |
| EBITDA | $-72.63M |
| Operating Margin | -38574.00% |
| Return on Equity | -105.60% |
| Return on Assets | -51.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.59 |
| Price-to-Book | 0.83 |
| Price-to-Sales (TTM) | 252.87 |
| EV/Revenue | 139.55 |
| EV/EBITDA | -0.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $98.05M |
| Float | $95.61M |
| % Insiders | 2.45% |
| % Institutions | 57.51% |
Historical Volatility
HV 10-Day
131.55%
HV 20-Day
97.97%
HV 30-Day
94.24%
HV 60-Day
83.70%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($2.86 target)
2
Strong Buy1
Buy6
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026